Item 7.01. Regulation FD Disclosure.

On January 6, 2021, Homology Medicines, Inc. (the "Company") posted a corporate slide presentation in the "Investors" portion of its website at investors.homologymedicines.com. A copy of its current corporate slide presentation is attached to this Current Report on Form 8-K as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

The information contained in Item 7.01 of this Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



The following exhibit relating to Item 7.01 shall be deemed to be furnished, and
not filed:



Exhibit
  No.       Description

99.1          Corporate Slide Presentation of Homology Medicines, Inc. dated
            January 6, 2021

104         Cover Page Interactive Data File (embedded within the inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses